Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease
Robert A. Hauser, Aaron Ellenbogen, Sarita Khanna, et al.
Neuropsychiatric Disease and Treatment (2018) Vol. Volume 14, pp. 839-845
Open Access | Times Cited: 17

Showing 17 citing articles:

Levodopa-loaded nanoparticles for the treatment of Parkinson's disease
Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 212-224
Open Access | Times Cited: 29
L‐DOPA for Parkinson's disease—a bittersweet pill
Emma L. Lane
European Journal of Neuroscience (2018) Vol. 49, Iss. 3, pp. 384-398
Open Access | Times Cited: 58
Progress of Pharmacological Approaches in Parkinson's Disease
Kirsten E. Zeuner, Eva Schäffer, Franziska Hopfner, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 105, Iss. 5, pp. 1106-1120
Closed Access | Times Cited: 40
Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies
Sarah R. Horn, Hayley Richardson, Sharon X. Xie, et al.
Parkinsonism & Related Disorders (2019) Vol. 69, pp. 119-124
Open Access | Times Cited: 34
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease
Nicola Brice, Hans H. Schiffer, Holger Monenschein, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 377, Iss. 3, pp. 407-416
Open Access | Times Cited: 25
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
Peter A. LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 18
Salidroside protected against MPP+‐induced Parkinson's disease in PC12 cells by inhibiting inflammation, oxidative stress and cell apoptosis
Feng Zhou, Jing Ju, Yongjun Fang, et al.
Biotechnology and Applied Biochemistry (2018) Vol. 66, Iss. 2, pp. 247-253
Closed Access | Times Cited: 29
On demand therapy for Parkinson’s disease patients: Opportunities and choices
Robert A. Hauser, Peter A. LeWitt, Cynthia L. Comella
Postgraduate Medicine (2021) Vol. 133, Iss. 7, pp. 721-727
Open Access | Times Cited: 18
Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson Disease
Thomas Müller, Jan-Dominique Möhr
Expert Opinion on Pharmacotherapy (2018) Vol. 19, Iss. 18, pp. 2063-2071
Closed Access | Times Cited: 18
Enzyme‐Triggered Intestine‐Specific Targeting Adhesive Platform for Universal Oral Drug Delivery
Ying Li, Jung Seung Lee, Ameya R. Kirtane, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 27
Open Access | Times Cited: 4
Treatment Detection and Movement Disorder Society‐Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks
Ahnjili Zhuparris, Eva Thijssen, Willem O Elzinga, et al.
Movement Disorders (2023) Vol. 38, Iss. 10, pp. 1795-1805
Open Access | Times Cited: 4
Exploring the electrophysiology of Parkinson’s disease with magnetoencephalography and deep brain recordings
Fayed Rassoulou, Alexandra Steina, Christian J. Hartmann, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Negative pressure pulmonary edema due to upper airway obstruction after general anesthesia in a patient with Parkinson's disease: A case report
Ayaka Hasegawa, Naoko Niimi, Chieko Mitaka, et al.
Clinical Case Reports (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 2
A simulated environment for early development stages of reinforcement learning algorithms for closed-loop deep brain stimulation
Sebastián Castaño-Candamil, Mara Vaihinger, Michael Tangermann
(2019), pp. 2900-2904
Closed Access | Times Cited: 4
The Effect of 8 Weeks of Otago Exercise on the Selected Walking Factors in Patients With Parkinson Disease
Faezeh Masoumi, Amirhossein Barati, Mohammad Rohani, et al.
Scientific Journal of Rehabilitation Medicine (2024), pp. 78-93
Open Access
Correlation of balance posturographic parameters during quiet standing with the Berg Balance Scale in patients with Parkinson’s disease
Wei Bao, Yuyan Tan, Ying Yang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Negative pressure pulmonary edema due to upper airway obstruction after general anesthesia in a patient with Parkinson’s disease: a case report
Ayaka Hasegawa, Naoko Niimi, Chieko Mitaka, et al.
Authorea (Authorea) (2023)
Open Access
Page 1

Scroll to top